Cargando…

Non-invasive measurement of tumor immune microenvironment and prediction of survival and chemotherapeutic benefits from (18)F fluorodeoxyglucose PET/CT images in gastric cancer

BACKGROUND: The tumor immune microenvironment could provide prognostic and predictive information. It is necessary to develop a noninvasive radiomics-based biomarker of a previously validated tumor immune microenvironment signature of gastric cancer (GC) with immunohistochemistry staining. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Junmeng, Zhang, Chao, Guo, Huihui, Li, Shuang, You, Yang, Zheng, Peiming, Zhang, Hongquan, Wang, Huanan, Bai, Junwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606753/ https://www.ncbi.nlm.nih.gov/pubmed/36311742 http://dx.doi.org/10.3389/fimmu.2022.1019386

Ejemplares similares

Radiomic signature of( 18)F fluorodeoxyglucose PET/CT for prediction of gastric cancer survival and chemotherapeutic benefits
por: Jiang, Yuming, et al.
Publicado: (2018)

The value of [(18)F]fluorodeoxyglucose-PET/CT in oesophageal cancer
por: Rankin, S.
Publicado: (2011)

Inflammatory Pseudotumor in the Mediastinum: Imaging with (18)F-Fluorodeoxyglucose PET/CT
por: Yoon, Seok-Ho, et al.
Publicado: (2013)

(18)F-Fluorodeoxyglucose PET/CT in a Patient with Esophageal and Genital Leiomyomatosis
por: An, Young-Sil, et al.
Publicado: (2009)

Primary hepatic (extranodal) lymphoma: utility of [(18)F]fluorodeoxyglucose-PET/CT
por: Seshadri, Nagabhushan, et al.
Publicado: (2010)

False-Negative 18F-Fluorodeoxyglucose PET/CT in Malignant Pleural Mesothelioma
por: Corbin, Haley, et al.
Publicado: (2021)

(18)Fluorine-fluorodeoxyglucose PET/CT Imaging in Childhood Malignancies
por: Bıçakçı, Nilüfer, et al.
Publicado: (2021)

Analysis of predictability of F‐18 fluorodeoxyglucose‐PET/CT in the recurrence of papillary thyroid carcinoma
por: Kim, Suk Kyeong, et al.
Publicado: (2016)

Relative clinical utility of simultaneous (18)F-fluorodeoxyglucose PET/MRI and PET/CT for preoperative cervical cancer diagnosis
por: Gong, Jing, et al.
Publicado: (2021)

F-18 Fluorodeoxyglucose PET/CT and Post Hoc PET/MRI in a Case of Primary Meningeal Melanomatosis
por: Lee, Hong Je, et al.
Publicado: (2013)

Central Pontine Myelinolysis and Localized Fluorodeoxyglucose Uptake Seen on (18)F-FDG PET/CT
por: Rønne, Frederik, et al.
Publicado: (2017)

Utility of (18)F-fluorodeoxyglucose PET-CT scan in detecting bone marrow involvement in lymphoma
por: Jitani, Ankit Kumar, et al.
Publicado: (2021)

An Exceptional Cause of Increased (18)F-Fluorodeoxyglucose Uptake on PET/CT in a Thyroid Nodule
por: Manta, Ringo, et al.
Publicado: (2023)

Pulmonary Actinomycosis Mimicking Pulmonary Cancer on Fluorine-18 Fluorodeoxyglucose PET-CT
por: Tanaka, Shota, et al.
Publicado: (2020)

Evaluation of the response chemotherapy for penile metastasis of bladder cancer using 18F-fluorodeoxyglucose-PET/CT
por: Öztürk, Hakan
Publicado: (2015)

Efficacy of (18)F-fluorodeoxyglucose PET/CT for Detecting Lymph Node Metastasis in Papillary Thyroid Carcinoma
por: Lee, Dong Won, et al.
Publicado: (2018)

Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma
por: Lim, Jun Hyeok, et al.
Publicado: (2020)

Takayasu arteritis detected by PET/MRI with (18)F-fluorodeoxyglucose
por: Takeishi, Yasuchika, et al.
Publicado: (2018)

The Prognostic Value of (18)F-Fluorodeoxyglucose PET/CT in the Initial Assessment of Primary Tracheal Malignant Tumor: A Retrospective Study
por: Shao, Dan, et al.
Publicado: (2021)

Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
por: Yang, Shan-Shan, et al.
Publicado: (2021)

Forced diuresis and dual-phase (18)F-fluorodeoxyglucose-PET/CT scan for restaging of urinary bladder cancers
por: Harkirat, S, et al.
Publicado: (2010)

Paraneoplastic ocular sarcoidosis in the setting of recurrent rectal carcinoid tumor diagnosed by F(18)-fluorodeoxyglucose PET CT
por: Marlow, Elizabeth D., et al.
Publicado: (2020)

Prevalence of incidental thyroid malignancy on routine (18)F-fluorodeoxyglucose PET-CT in a large teaching hospital
por: Roddy, Shea, et al.
Publicado: (2020)

Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas
por: Maccioni, Francesca, et al.
Publicado: (2023)

Diagnostic Value of Volume-Based Fluorine-18-Fluorodeoxyglucose PET/CT Parameters for Characterizing Thyroid Incidentaloma
por: Shi, Huazheng, et al.
Publicado: (2018)

Tumor Microenvironment Features as Predictive Biomarkers in Metastatic Differentiated Thyroid Cancer and Their Relationship With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Metabolic Parameters
por: Soyluoglu, Selin, et al.
Publicado: (2023)

Effects of blood glucose level on 18F fluorodeoxyglucose (18F-FDG) uptake for PET/CT in normal organs: an analysis on 5623 patients
por: Sprinz, Clarice, et al.
Publicado: (2018)

Cardiac imaging with (18)F-fluorodeoxyglucose PET/MRI in hypertrophic cardiomyopathy
por: Takeishi, Yasuchika, et al.
Publicado: (2016)

18-F-FDG PET-CT in Monitoring of Chemotherapeutic Effect in a Case of Metastatic Hepatic Epithelioid Hemangioendothelioma
por: Shamim, Shamim Ahmed, et al.
Publicado: (2017)

Clinical Utility of (18)Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography ((18)F-FDG PET/CT) in Multivisceral Transplant Patients
por: Ong, Shao Jin, et al.
Publicado: (2023)

Re: Diagnostic Value of Volume-Based Fluorine-18-Fluorodeoxyglucose PET/CT Parameters for Characterizing Thyroid Incidentaloma
por: Zhang, Jinshan, et al.
Publicado: (2019)

PET Imaging of Hepatocellular Carcinomas: (18)F-Fluoropropionic Acid as a Complementary Radiotracer for (18)F-Fluorodeoxyglucose
por: Zhao, Jing, et al.
Publicado: (2019)

Clinical utility of 18 Fluorodeoxyglucose (FDG)-PET/CT scans in patients with suspect ocular tuberculosis
por: Mehta, Salil
Publicado: (2013)

Fluorine-18-Fluorodeoxyglucose PET/CT Proved Valvular Endocarditis in a Native Valve Patient
por: Dhanasekaran, Pavithra, et al.
Publicado: (2023)

(18)F-Fluorodeoxyglucose Uptake and Tumor Hypoxia: Revisit (18)F-Fluorodeoxyglucose in Oncology Application
por: Li, Xiao-Feng, et al.
Publicado: (2014)

18F‐fluorodeoxyglucose uptake in PET is associated with the tumor microenvironment in metastatic lymph nodes and prognosis in N2 lung adenocarcinoma
por: Nomura, Kotaro, et al.
Publicado: (2022)

The Influence of Interpreters’ Professional Background and Experience on the Interpretation of Multimodality Imaging of Pulmonary Lesions Using( 18)F-3′-Deoxy-Fluorothymidine and (18)F-Fluorodeoxyglucose PET/CT
por: Xu, Bai-xuan, et al.
Publicado: (2013)

Combination of (18)F-Fluorodeoxyglucose PET/CT Radiomics and Clinical Features for Predicting Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma
por: Li, Shen, et al.
Publicado: (2022)

Prognostic Value of Baseline (18)F-Fluorodeoxyglucose PET/CT in Patients with Multiple Myeloma: A Multicenter Cohort Study
por: Moon, Seung Hwan, et al.
Publicado: (2018)

(18)F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine
por: Steinberg, Julie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_up0338rsh2577dolnkhlj78kep